Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure

The meaning and use of the area under a receiver operating characteristic (ROC) curve.

Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856

Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure

Levine, B., Kalman, J., Mayer, L., Fillit, H. M., & Packer, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007263230405 · Cited by 2,582

Wasting as independent risk factor for mortality in chronic heart failure

Anker, S. D., Ponikowski, P. P., Varney, S. J., Chua, T. P., Clark, A. L., Webb-Peploe, K., Harrington, D., Kox, W. J., Poole-Wilson, P. A., & Coats, A. J. S. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07015-8 · Cited by 1,399

Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)

Torre-Amione, G., Kapadia, S., Benedict, C., Oral, H., Young, J. B., & Mann, D. L. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00589-7 · Cited by 1,211

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.

Swedberg, K. B., Eneroth, P. H. E., KJEKSHUS, J. K., & Wilhelmsen, L. (1990) · Circulation · doi:10.1161/01.cir.82.5.1730 · Cited by 1,147

Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart

Torre‐Amione, G., Kapadia, S. R., Lee, J. J., Durand, J., Bies, R. D., Young, J. B., & Mann, D. L. (1996) · Circulation · doi:10.1161/01.cir.93.4.704 · Cited by 991

Endotoxin and immune activation in chronic heart failure: a prospective cohort study

Niebauer, J., Volk, H.-D., Kemp, M., Dominguez, M., Schumann, R. R., Rauchhaus, M., Poole-Wilson, P. A., Coats, A. J., & Anker, S. D. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09286-1 · Cited by 877

Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia

Anker, S. D., Chua, T. P., Ponikowski, P., Harrington, D., Swan, J. W., Kox, W. J., Poole-Wilson, P. A., & Coats, A. J. S. (1997) · Circulation · doi:10.1161/01.cir.96.2.526 · Cited by 800

Mechanisms and Models in Heart Failure

Mann, D. L. (1999) · Circulation · doi:10.1161/01.cir.100.9.999 · Cited by 769

Plasma Brain Natriuretic Peptide as an Indicator of Left Ventricular Systolic Function and Long-term Survival After Acute Myocardial Infarction

Omland, T., Aakvaag, A., Bonarjee, V., Caidahl, K., Lie, R. T., Nilsen, D. W. T., Sundsfjord, J., & Dickstein, K. (1996) · Circulation · doi:10.1161/01.cir.93.11.1963 · Cited by 698

Prognostic Factors in Chronic Heart Failure

Lainščak, M., & Anker, S. D. (2009) · Herz · doi:10.1007/s00059-009-3211-z · Cited by 27

Tumor necrosis factor-α blockade as a therapeutic strategy in heart failure (RENEWAL and ATTACH): Unsuccessful, to be specific

Krum, H. (2002) · Journal of Cardiac Failure · doi:10.1054/jcaf.2002.130237 · Cited by 27

Therapeutic applications of gut microbes in cardiometabolic diseases: current state and perspectives

Yuan, L., Li, Y., Chen, M., Xue, L., Wang, J., Ding, Y., Gu, Q., Zhang, J., Zhao, H., Xie, X., et al. (2024) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-024-13007-7 · Cited by 28

Human cardiac fibroblasts isolated from patients with severe heart failure are immune-competent cells mediating an inflammatory response

Sandstedt, J., Sandstedt, M., Lundqvist, A., Jansson, M., Sopasakis, V. R., Jeppsson, A., & Hultén, L. M. (2018) · Cytokine · doi:10.1016/j.cyto.2018.09.021 · Cited by 26

Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study

Tassell, B. W. V., Mihalick, V. L., THOMAS, G. K., Marawan, A., Talasaz, A. H., Lü, J., Kang, L., Ladd, A. C., Damonte, J. I., Dixon, D. L., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03466-9 · Cited by 26

Cardio-sarcopenia: A syndrome of concern in aging

Loh, D. R., Tan, R., Lim, W. S., & Koh, A. S.-M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1027466 · Cited by 25

Autoantibodies against G-protein-coupled receptors modulate heart mast cells.

Okruhlicová, Ľ., Morwinski, R., Schulze, W., Bartel, S., Weismann, P., Tribulová, N., & Wallukat, G. (2007) · PubMed · Cited by 26

Efeitos antioxidantes do selênio e seu elo com a inflamação e síndrome metabólica

Volp, A. C. P., Bressan, J., Hermsdorff, H. H. M., Zulet, M. Á., & Martínez, J. A. (2010) · Revista de Nutrição · doi:10.1590/s1415-52732010000400009 · Cited by 27

Cardiac Impairment in Rheumatoid Arthritis and Influence of Anti-TNFα Treatment

Lazúrová, I., & Tomáš, Ľ. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8566-3 · Cited by 27

Inflammation and anaemia in a broad spectrum of patients with heart failure

Kleijn, L., Belonje, A. M. S., Voors, A. A., de Boer, R. A., Jaarsma, T., Ghosh, S., Kim, J., Hillege, H. L., van Gilst, W. H., van Veldhuisen, D. J., et al. (2012) · Heart · doi:10.1136/heartjnl-2012-301954 · Cited by 25

Increased risk of cancer death in patients with chronic heart failure with a special reference to inflammation-A report from the CHART-2 Study

Oikawa, T., Sakata, Y., Nochioka, K., Miura, M., Abe, R., Kasahara, S., Sato, M., Aoyanagi, H., Shiroto, T., Sugimura, K., et al. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.04.078 · Cited by 25

Heart Failure With Preserved Ejection Fraction

Desai, A. S. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.03.075 · Cited by 25

CD4+CD28null cells are an independent predictor of mortality in patients with heart failure

Koller, L., Richter, B., Goliasch, G., Blum, S., Korpak, M., Zorn, G., Brekalo, M., Maurer, G., Wojta, J., Pacher, R., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.08.008 · Cited by 25

Multimarker approach for heart failure management: Perspectives and limitations

Giannessi, D. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.03.006 · Cited by 26

Spironolactone, not furosemide, improved insulin resistance in patients with chronic heart failure

Oginö, K., Kinugasa, Y., Kato, M., Yamamoto, K., Hisatome, I., Anker, S. D., & Doehner, W. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.12.039 · Cited by 27

Are circulating cytokine responses to exercise in the heat augmented in older men?

Wright, H. E., McLellan, T. M., Larose, J., Hardcastle, S. G., Boulay, P., & Kenny, G. P. (2013) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2013-0223 · Cited by 24

Physiologic Testosterone Therapy has no Effect on Serum Levels of Tumour Necrosis Factor-α in Men with Chronic Heart Failure

Pugh, P. J., Jones, R. D., Malkin, C. J., Hall, J., Nettleship, J. E., Kerry, K., Jones, T. H., & Channer, K. S. (2005) · Endocrine Research · doi:10.1080/07435800500406205 · Cited by 25

Utilidad clínica de los marcadores neurohormonales en la insuficiencia cardíaca

Roig, E. S. (2004) · Revista Española de Cardiología · doi:10.1016/s0300-8932(04)77113-4 · Cited by 25

Presepsin: solving a soluble (CD14) problem in sepsis?

Ackland, G. L., & Prowle, J. R. (2015) · Intensive Care Medicine · doi:10.1007/s00134-014-3642-8 · Cited by 25

Neuroimmune cross-talk in heart failure

Montuoro, S., Gentile, F., & Giannoni, A. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae236 · Cited by 25

The role of immune checkpoints PD-1 and CTLA-4 in cardiovascular complications leading to heart failure

Huang, S., Kang, Y., Liu, T., Xiong, Y., Yang, Z., & Zhang, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1561968 · Cited by 28

Heart Failure Results in Inspiratory Muscle Dysfunction Irrespective of Left Ventricular Ejection Fraction

Spießhoefer, J., Henke, C., Kabitz, H., Bengel, P., Schütt, K. S., Nofer, J., Spieker, M., Orwat, S., Diller, G., Strecker, J., et al. (2020) · Respiration · doi:10.1159/000509940 · Cited by 24

Neurohormonal activity and vascular properties late after aortic coarctation repair

Moutafi, A. C., Alissafi, T., Chamakou, A. C., Chryssanthopoulos, S., Thanopoulos, V., Dellos, C., Xanthou, G., Tousoulis, D., Stefanadis, C., Gatzoulis, M. Α., et al. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.02.071 · Cited by 24

Relationship Between Exercise Intolerance and Levels of Neurohormonal Factors and Proinflammatory Cytokines in Patients With Stable Chronic Heart Failure

Itoh, K., Osada, N., Inoue, K., Samejima, H., Seki, A., Omiya, K., & Miyake, F. (2005) · International Heart Journal · doi:10.1536/ihj.46.1049 · Cited by 24

Cystatin C, NT-proBNP, and inflammatory markers in acute heart failure: insights into the cardiorenal syndrome

Lassus, J. P. E., Harjola, V., PEUHKURINEN, K. J., Sund, R., Mebazaa, A., Siirilä‐Waris, K., Miettinen, K. H., Punnonen, K. R. A., Melin, J., Pulkki, K. J., et al. (2011) · Biomarkers · doi:10.3109/1354750x.2011.555822 · Cited by 24

Ativação imune-inflamatória na insuficiência cardíaca

de Candia, A. M., Villacorta, H., & Mesquita, E. T. (2007) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2007001500009 · Cited by 24

Vitamin D: Evidence and Controversies

Gilaberte, Y., Aguilera, J. M., Carrascosa, J. M., Figueroa, F. L., Romaní, J., & Nagore, E. (2011) · Actas Dermo-Sifiliográficas · doi:10.1016/j.adengl.2011.03.013 · Cited by 24

Somatic Depression Predicts Mortality in Chronic Heart Failure

Smith, O. R. F., Kupper, N. H. M., Schiffer, A. A., & Denollet, J. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31824ef2f4 · Cited by 24

Current and future developments in the field of central sleep apnoea

Bekfani, T., & Abraham, W. T. (2016) · EP Europace · doi:10.1093/europace/euv435 · Cited by 25

Inflammatory responses of older Firefighters to intermittent exercise in the heat

Wright, H. E., McLellan, T. M., Larose, J., Sigal, R. J., Boulay, P., & Kenny, G. P. (2014) · European Journal of Applied Physiology · doi:10.1007/s00421-014-2843-8 · Cited by 23

Inspiratory muscle dysfunction and restrictive lung function impairment in congenital heart disease: Association with immune inflammatory response and exercise intolerance

Spießhoefer, J., Orwat, S., Henke, C., Kabitz, H., Katsianos, S., Borrelli, C., Baumgartner, H., Nofer, J., Spieker, M., Bengel, P., et al. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.06.055 · Cited by 23

Pathophysiology of cachexia and characteristics of dysphagia in chronic diseases

Matsuo, H., & Sakuma, K. (2022) · Asia-Pacific Journal of Oncology Nursing · doi:10.1016/j.apjon.2022.100120 · Cited by 24

Cytokine Activation and Disease Progression in Patients With Stable Moderate Chronic Heart Failure

Tanner, H., Mohaçsi, P., Fuller-Bicer, G. A., Rieben, R., Meier, B., Hess, O. M., & Hullin, R. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2007.01.033 · Cited by 23

Patient-Rated Changes in Fatigue Over a 12-Month Period Predict Poor Outcome in Chronic Heart Failure

Smith, O. R. F., Denollet, J., Schiffer, A. A., Kupper, N. H. M., & Gidron, Y. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp002 · Cited by 23

Relation of baseline plasma phospholipid transfer protein (PLTP) activity to left ventricular systolic dysfunction in patients referred for coronary angiography

Çavuşoğlu, E., Marmur, J. D., Chhabra, S., Chopra, V., Eng, C., & Jiang, X.-C. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.04.011 · Cited by 23

Upregulation of Monocyte Proinflammatory Cytokine Production by C-Reactive Protein is Significantly Related to Ongoing Myocardial Damage and Future Cardiac Events in Patients With Chronic Heart Failure

Nakagomi, A., Seino, Y., Endoh, Y., Kusama, Y., Atarashi, H., & Mizuno, K. (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.02.003 · Cited by 23

The anti-CD14 Antibody IC14 Suppresses Ex Vivo Endotoxin Stimulated Tumor Necrosis Factor-Alpha in Patients with Chronic Heart Failure

Genth‐Zotz, S., von Haehling, S., Bolger, A. P., Kalra, P. R., Wensel, R., Coats, A. J. S., Volk, H., & Anker, S. D. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.10.010 · Cited by 23

Accuracy of 64-slice multidetector computed tomography for classification and quantitation of coronary plaque: Comparison with integrated backscatter intravascular ultrasound

Harada, K., Amano, T., Uetani, T., Funahashi, H., Arai, K., Okada, K., Hirashiki, A., Hayashi, M., Ooshima, S., Ishii, H., et al. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.04.002 · Cited by 22

The Role of Inflammasomes in Heart Failure

Vlachakis, P. K., Theofilis, P., Kachrimanidis, I., Giannakopoulos, K., Drakopoulou, M. I., Apostolos, A., Kordalis, A., Leontsinis, I., Tsioufis, K. P., & Tousoulis, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105372 · Cited by 24

IL-18 stimulates B-type natriuretic peptide synthesis by cardiomyocytesin vitroand its plasma levels correlate with B-type natriuretic peptide innon-overloadedacute heart failure patients

Somma, S. D., Pittoni, V., Raffa, S., Magrini, L., Gagliano, G., Marino, R., Nobili, V., & Torrisi, M. R. (2013) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872613499282 · Cited by 22

Mechanisms and Perspectives of Sodium-Glucose Co-transporter 2 Inhibitors in Heart Failure

Zeng, Q., Zhou, Q., Liu, W., Wang, Y., Xu, X., & Xu, D. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.636152 · Cited by 23

Gastrointestinal changes associated to heart failure.

Romeiro, F. G., Okoshi, K., Zornoff, L. A. M., & Okoshi, M. P. (2012) · PubMed · Cited by 22

The inhibition in tumor necrosis factor-α-induced attenuation in endothelial thrombomodulin expression by carvedilol is mediated by nuclear factor-κB and reactive oxygen species

Lin, P.-Y., Shen, H., Chen, C., Wu, S.-E., Kao, H., Huang, J.-H., Wang, D. L., & Chen, S.-C. (2009) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-009-0318-2 · Cited by 22

Immunological aspects of the statins' function in patients with heart failure: a report from the Annual Conference of ESC - Heart Failure 2005.

Banach, M., Dróżdż, J., Okoński, P., & Rysz, J. (2005) · PubMed · Cited by 22

Endothelin-1 Concentrations in Pericardial Fluid Are More Elevated in Patients with Ischemic Heart Disease Than in Patients With Nonischemic Heart Disease

Namiki, A., Kubota, T., Fukazawa, M., Ishikawa, M., Moroi, M., Aikawa, J., Ebine, K., & Yamaguchi, T. (2003) · Japanese Heart Journal · doi:10.1536/jhj.44.633 · Cited by 22

Plasma concentrations of tumor necrosis factor-α in cats with congestive heart failure

Meurs, K. M., Fox, P. R., Miller, M. W., Kapadia, S. R., & Mann, D. L. (2002) · American Journal of Veterinary Research · doi:10.2460/ajvr.2002.63.640 · Cited by 22

Serum HMGB1 is a biomarker for acute myocardial infarction with or without heart failure

Wahid, A., Wen, J., Yang, Q., Zhang, Z., Zhao, X., & Tang, X. (2023) · Clinical and Translational Science · doi:10.1111/cts.13630 · Cited by 21

Heart Failure and Pancreas Exocrine Insufficiency: Pathophysiological Mechanisms and Clinical Point of View

Dams, O. C., Vijver, M. A. T., van Veldhuisen, C. L., Verdonk, R. C., Besselink, M. G., & van Veldhuisen, D. J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11144128 · Cited by 21

Role and benefits of exercise in the management of patients with heart failure

Keteyian, S. J., Fleg, J. L., Brawner, C. A., & Piña, I. L. (2010) · Heart Failure Reviews · doi:10.1007/s10741-009-9157-7 · Cited by 21

The inflammatory markers sST2, HSP27 and hsCRP as a prognostic biomarker panel in chronic heart failure patients

Traxler, D., Zimmermann, M., Simader, E., Veraar, C., Moser, B., Mueller, T., Mildner, M., Dannenberg, V., Lainščak, M., Jug, B., et al. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.07.050 · Cited by 21

Role of Vitamin D Supplementation in Heart Failure Patients With Vitamin D Deficiency and Its Effects on Clinical Outcomes: A Literature Review

Busa, V., Dardeir, A., Marudhai, S., Patel, M., Subas, S. V., Ghani, M. R., & Cancarevic, I. (2020) · Cureus · doi:10.7759/cureus.10840 · Cited by 24

Effect of pericardial fluid pro-inflammatory cytokines on hemodynamic parameters

Ege, T. (2003) · Cytokine · doi:10.1016/s1043-4666(03)00180-7 · Cited by 21

Activation of the NF-κB System in Peripheral Blood Leukocytes from Patients with Chronic Heart Failure

Jankowska, E. A., von Haehling, S., Czarny, A., Zaczyńska, E., Kuś, A., Anker, S. D., Banasiak, W., & Ponikowski, P. P. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.05.013 · Cited by 21

Association of lipoproteins with cytokines and cytokine receptors in heart failure patients Differences between ischaemic versus idiopathic cardiomyopathy

Conraads, V. M. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.09.023 · Cited by 21

The Relationship Between Functional Status and Inflammatory Disease in Older Adults

Thomas, D. R. (2003) · The Journals of Gerontology Series A · doi:10.1093/gerona/58.11.m995 · Cited by 21

Why Is Iron Deficiency/Anemia Linked to Alzheimer’s Disease and Its Comorbidities, and How Is It Prevented?

Fehsel, K. (2023) · Biomedicines · doi:10.3390/biomedicines11092421 · Cited by 20

Towards clinical application of GlycA and GlycB for early detection of inflammation associated with (pre)diabetes and cardiovascular disease: recent evidence and updates

Fung, E., Chan, E. Y. S., Ng, K. H., Yu, K. M., Li, H., & Wang, Y. (2023) · Journal of Inflammation · doi:10.1186/s12950-023-00358-7 · Cited by 20

Cardiac rehabilitation decreases plasma pentraxin 3 in patients with cardiovascular diseases

Fukuda, T., Kurano, M., Iida, H., Takano, H., Tanaka, T., Yamamoto, Y., Ikeda, K., Nagasaki, M., Monzen, K., Uno, K., et al. (2011) · European Journal of Preventive Cardiology · doi:10.1177/1741826711422990 · Cited by 20

Ca2+ mishandling in heart failure: Potential targets

Val‐Blasco, A., Fernández, M. G., Rueda, A., Pereira, L., Delgado, C., Smani, T., Ruiz‐Hurtado, G., & Fernández‐Velasco, M. (2021) · Acta Physiologica · doi:10.1111/apha.13691 · Cited by 20

Valor pronóstico del factor de necrosis tumoral alfa en pacientes con infarto agudo de miocardio con elevación del segmento ST

Gonzálvez, M., Ruiz‐Ros, J. A., Pérez-Paredes, M., Lozano, M. L., García‐Almagro, F. J., Martínez-Corbalán, F., Giménez, D. M., Andrés, C., Carnero, A., Cubero, T., et al. (2007) · Revista Española de Cardiología · doi:10.1157/13113928 · Cited by 20

Inhalation exposure to chemicals, microbiota dysbiosis and adverse effects on humans

Utembe, W., & Kamng’ona, A. W. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.176938 · Cited by 21

Aging at the Crossroads of Organ Interactions: Implications for the Heart

Sen, I., Trzaskalski, N. A., Hsiao, Y., Liu, P. P., Shimizu, I., & Dérumeaux, G. (2025) · Circulation Research · doi:10.1161/circresaha.125.325637 · Cited by 20

Present and future pharmacotherapeutic agents in heart failure: an evolving paradigm

Loudon, B. L., Noordali, H., Gollop, N. D., Frenneaux, M. P., & Madhani, M. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13480 · Cited by 20

CMV Infection Is Directly Related to the Inflammatory Status in Chronic Heart Failure Patients

García‐Torre, A., Bueno‐García, E., López‐Martínez, R., Rioseras, B., Molina, B. D., Lambert, J. L., Quirós, C., Alonso, S., Alonso‐Arias, R., & Moro‐García, M. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.687582 · Cited by 19

The pro-apoptotic serum activity is an independent mortality predictor of patients with heart failure

Rössig, L., Fichtlscherer, S., Heeschen, C., BERGER, J., Dimmeler, S., & Zeiher, A. M. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.036 · Cited by 19

Interleukin-1 receptor antagonist reduces the magnitude of the pressor response to acute stress

Ufnal, M., Sikora, M., & Szczepanska‐Sadowska, E. K. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.10.010 · Cited by 19

What We May Expect from Biomarkers in Heart Failure

Richards, M. (2009) · Heart Failure Clinics · doi:10.1016/j.hfc.2009.04.011 · Cited by 19

Impact of Ivabradine on Inflammatory Markers in Chronic Heart Failure

Rohm, I., Kretzschmar, D., Pistulli, R., Franz, M., Schulze, P. C., Stumpf, C., & Yılmaz, A. (2016) · Journal of Immunology Research · doi:10.1155/2016/6949320 · Cited by 19

Anticoagulation Therapy and NOACs in Heart Failure

Thomas, I. C., EncisoSilva, J., Schlueter, M., & Greenberg, B. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_126 · Cited by 19

Epigenetics, inflammation and metabolism in right heart failure associated with pulmonary hypertension

Samson, N., & Paulin, R. (2017) · Pulmonary Circulation · doi:10.1177/2045893217714463 · Cited by 19

Smoking, white blood cell counts, and TNF system activity in Japanese male subjects with normal glucose tolerance

Watanabe, N., Fukushima, M., Taniguchi, A., Okumura, T., Nomura, Y., Nishimura, F., Aoyama, S., Yabe, D., Izumi, Y., Ohtsubo, R., et al. (2011) · Tobacco Induced Diseases · doi:10.1186/1617-9625-9-12 · Cited by 19

Lipopolysaccharide responsiveness is an independent predictor of death in patients with chronic heart failure

Ebner, N., Földes, G., Schomburg, L., Renko, K., Springer, J., Jankowska, E. A., Sharma, R., Genth‐Zotz, S., Doehner, W., Anker, S. D., et al. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.07.029 · Cited by 18

Risk stratification in patients with chronic heart failure based on metabolic-immunological, functional and haemodynamic parameters

Herrmann, R., Sandek, A., von Haehling, S., Doehner, W., Schmidt, H. B., Anker, S. D., & Rauchhaus, M. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.10.028 · Cited by 18

Depressive symptoms and inflammatory biomarkers in patients with heart failure

Dekker, R. L., Moser, D. K., Tovar, E. G., Chung, M. L., Heo, S., Wu, J., Dunbar, S. B., Pressler, S. J., & Lennie, T. A. (2013) · European Journal of Cardiovascular Nursing · doi:10.1177/1474515113507508 · Cited by 18

Association of Soluble Interleukin-2 Receptor α and Tumour Necrosis Factor Receptor 1 with Heart Failure: The Multi-Ethnic Study of Atherosclerosis

Bakhshi, H., Varadarajan, V., Ambale‐Venkatesh, B., Meyghani, Z., Ostovaneh, M. R., Durda, P., Wu, C. O., Tracy, R. P., Cushman, M., Bluemke, D. A., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12623 · Cited by 18

Pentoxifylline for heart failure: a systematic review.

Batchelder, K., & Mayosi, B. M. (2005) · PubMed · Cited by 18

Prognostic Significance of Left Ventricular Diastolic Function in Burn Patients

Lin, C., Wu, C., Yeong, E., Lin, H., Huang, Y.-T., Lee, J., Lin, Y.-H., Chiang, F., Tang, Y., & Tsai, C. (2012) · Shock · doi:10.1097/shk.0b013e31824caa72 · Cited by 18

Beta-Blockade Does Not Alter Plasma Cytokine Concentrations and Ventricular Function in Young Adults With Right Ventricular Dysfunction Secondary to Operated Congenital Heart Disease

Norozi, K., Buchhorn, R., Wessel, A., Bahlmann, J., Raab, B. W., Geyer, S., Kühne, T., Li, B., Werdan, K., & Loppnow, H. (2008) · Circulation Journal · doi:10.1253/circj.72.747 · Cited by 18

Role of erythropoietin in anemia after heart transplantation

Gleissner, C. A., Klingenberg, R., Staritz, P., Koch, A., Ehlermann, P., Wiggenhauser, A., & Dengler, T. J. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.10.007 · Cited by 18

The relationship between age and production of tumour necrosis factor-α in healthy volunteers and patients with chronic heart failure

von Haehling, S., Genth‐Zotz, S., Sharma, R. K., Bolger, A. P., Doehner, W., Barnes, P. J., Coats, A. J. S., & Anker, S. D. (2003) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00566-1 · Cited by 18

Valor pronóstico de los niveles de citocinas y neurohormonas en la insuficiencia cardíaca severa

Vidal, B., Roig, E. S., Pérez‐Villa, F., Orús, J., Perez, J. U., Cuppoletti, A., Roqué, M., Sanz, G., Jiméneza, V., & Leivas, A. (2002) · Revista Española de Cardiología · doi:10.1016/s0300-8932(02)76639-6 · Cited by 18

Paradox of circulating advanced glycation end product concentrations in patients with congestive heart failure and after heart transplantation

Heidland, A., Šebeková, K., Frangiosa, A., Santo, L. S. D., Círillo, M., Rossi, F., Cotrufo, M., Perna, A. F., Klassen, A., Schinzel, R., et al. (2004) · Heart · doi:10.1136/hrt.2003.026989 · Cited by 18

The role of anticytokine therapy in heart failure: recent lessons from preclinical and clinical trials?

Feldman, A. M., Kadokami, T., Higuichi, Y., Ramani, R. N., & McTiernan, C. F. (2003) · Medical Clinics of North America · doi:10.1016/s0025-7125(02)00189-x · Cited by 18

Psychosomatic syndromes are associated with IL-6 pro-inflammatory cytokine in heart failure patients

Altamura, M., D’Andrea, G., Angelini, E., Tortorelli, F. M. P., Balzotti, A., Porcelli, P., Margaglione, M., Brunetti, N. D., Cassano, T., & Bellomo, A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265282 · Cited by 17

Relation of impaired interorgan communication and parasympathetic activity in chronic heart failure and multiple-organ dysfunction syndrome

Schmidt, H., Lotze, U., Ghanem, A., Anker, S. D., Said, S. M., Braun-Dullaeus, R. C., Oltmanns, G., Rose, S., Buerke, M., Müller‐Werdan, U., et al. (2014) · Journal of Critical Care · doi:10.1016/j.jcrc.2013.12.015 · Cited by 17

Energy Metabolism and Nutritional Status in Hospitalized Patients with Chronic Heart Failure

Yasuhara, S., Maekawa, M., Bamba, S., Kurihara, M., Nakanishi, N., Yamamoto, T., Sakai, H., Yagi, N., Nakagawa, Y., & Sasaki, M. (2020) · Annals of Nutrition and Metabolism · doi:10.1159/000507355 · Cited by 17

Circulating Levels of Tumor Necrosis Factor-α Correlate Positively with Severity of Peripheral Oedema in Patients with Right Heart Failure

Odeh, M., Sabo, E., & Oliven, A. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.05.010 · Cited by 17

Cachexia in chronic heart failure: endocrine determinants and treatment perspectives

Mangner, N., Matsuo, Y., Schuler, G. C., & Adams, V. (2012) · Endocrine · doi:10.1007/s12020-012-9767-z · Cited by 17

Expanded Network of Inflammatory Markers of Atherogenesis: Where Are We Now?~!2009-11-07~!2009-12-10~!2010-02-22~!

Abbasi, S. H., & Boroumand, M. A. (2010) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401004020038 · Cited by 17

Heat shock protein 27 acts as a predictor of prognosis in chronic heart failure patients

Traxler, D., Lainščak, M., Simader, E., Ankersmit, H. J., & Jug, B. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.08.028 · Cited by 18

Biochemical markers of cardiac dysfunction in children with obstructive sleep apnoea (OSA)

Hirsch, D. S., Evans, C. A., Wong, M., Machaalani, R., & Waters, K. A. (2018) · Sleep And Breathing · doi:10.1007/s11325-018-1666-y · Cited by 16

The Prognostic Impact of Circulating Regulatory T Lymphocytes on Mortality in Patients with Ischemic Heart Failure with Reduced Ejection Fraction

Hammer, A., Sulzgruber, P., Koller, L., Kazem, N., Hofer, F., Richter, B., Blum, S., Hülsmann, M., Wojta, J., & Niessner, A. (2020) · Mediators of Inflammation · doi:10.1155/2020/6079713 · Cited by 16

Epigenetics and Gut Microbiota Crosstalk: A potential Factor in Pathogenesis of Cardiovascular Disorders

Mehta, V., Nagu, P., Inbaraj, B. S., Sharma, M., Parashar, A., & Sridhar, K. (2022) · Bioengineering · doi:10.3390/bioengineering9120798 · Cited by 17

The sGCa Vericiguat Exhibit Cardioprotective and Anti-Sarcopenic Effects through NLRP-3 Pathways: Potential Benefits for Anthracycline-Treated Cancer Patients

Quagliariello, V., Berretta, M., Bisceglia, I., Giacobbe, I., Iovine, M., Giordano, V., Arianna, R., Barbato, M., Izzo, F., Maurea, C., et al. (2024) · Cancers · doi:10.3390/cancers16081487 · Cited by 17

Observational Studies of Statins in Heart Failure with Preserved Systolic Function

Fukuta, H., & Little, W. C. (2008) · Heart Failure Clinics · doi:10.1016/j.hfc.2008.01.005 · Cited by 16

Clinical Use of Markers of Neurohormonal Activation in Heart Failure

Roig, E. S. (2004) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(06)60159-x · Cited by 16

Biomarkers in the clinical management of patients with atrial fibrillation and heart failure.

Koniari, I. C., Artopoulou, E., Velissaris, D., Ainslie, M., Mplani, V., Karavasili, G., Kounis, N. G., & Tsigkas, G. (2021) · PubMed Central · doi:10.11909/j.issn.1671-5411.2021.11.010 · Cited by 16

Vitamin D levels predict hospitalization and mortality in patients with heart failure

Belen, E., Sungur, A., & Sungur, M. A. (2015) · Scandinavian Cardiovascular Journal · doi:10.3109/14017431.2015.1098725 · Cited by 16

Intermittent levosimendan treatment in patients with severe congestive heart failure

Tuomainen, P. O., Magga, J., Timonen, P., Miettinen, K. H., Kurttila, M., Vanninen, E. J., Laitinen, T. P., Timonen, K. L., Punnonen, K. R. A., Parviainen, I., et al. (2013) · Clinical Research in Cardiology · doi:10.1007/s00392-013-0554-5 · Cited by 15

Neutrophil-to-lymphocyte ratio is increased in dogs with acute congestive heart failure secondary to myxomatous mitral valve disease compared to both dogs with heart murmurs and healthy controls

DeProspero, D. J., Hess, R. S., & Silverstein, D. C. (2023) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.23.03.0131 · Cited by 19

Proinflammatory cytokines and mortality in heart failure

Xiang, Z. (2004) · Practical Journal of Clinical Medicne

The value of plasma levels of tumor necrosis factor-alpha and interleukin-6 in predicting the severity and prognosis in patients with congestive heart failure.

Pan, J.-P., Liu, T.-Y., Chiang, S. C., Lin, Y., Chou, C. Y., Chan, W., & Lai, S. (2004) · PubMed · Cited by 24

Tumor Necrosis Factor-α Receptor 1 Is a Major Predictor of Mortality and New-Onset Heart Failure in Patients With Acute Myocardial Infarction

Valgimigli, M., Ceconi, C., Malagutti, P., Merli, E., Soukhomovskaia, O., Francolini, G., Cicchitelli, G., Olivares, A., Parrinello, G., Percoco, G., et al. (2005) · Circulation · doi:10.1161/01.cir.0000155614.35441.69 · Cited by 208

Plasma Level of Cardiotrophin-1 as a Prognostic Predictor in Patients with Chronic Heart Failure

Tsutamoto, T., Asai, S., Tanaka, T., Sakai, H., Nishiyama, K., Fujii, M., Yamamoto, T., Ohnishi, M., Wada, A., Saito, Y., et al. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2007.07.015 · Cited by 39

The Role of Serum VCAM ‐1 and TNF ‐α as Predictors of Mortality and Morbidity in Patients with Chronic Heart Failure

Savic-Radojevic, A. R., Radovanović, S., Pekmezovic, T. D., Pljesa-Ercegovac, M. S., Simic, D. V., Djukic, T. I., Matic, M. G., & Simic, T. P. (2013) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21570 · Cited by 28